Ying Mu
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 6
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 5
- Biochemistry top 10%
- Hepatology top 10%
-
- HIV Research and Treatment 4
-
- Cholesterol and Lipid Metabolism 3
-
- HIV/AIDS drug development and treatment 3
-
- Liver Disease Diagnosis and Treatment 2
-
- Estrogen and related hormone effects 2
-
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Wen XieHirdesh UppalSongrong RenDavid TomaS. P. S. SainiHaibiao GongRonald M. EvansYonggong Zhai
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Ying Mu
23 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 406
- Endocrinology, Diabetes and Metabolism 265
- Oncology 425
- Biochemistry 72
- Hepatology 77
Countries citing papers authored by Ying Mu
This map shows the geographic impact of Ying Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Mu more than expected).
Fields of papers citing papers by Ying Mu
This network shows the impact of papers produced by Ying Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Mu. The network helps show where Ying Mu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 16 | |
| 3 | 2020 | 9 | |
| 4 | 2019 | 62 | |
| 5 | 2018 | 16 | |
| 6 | 2018 | 8 | |
| 7 | 2018 | 13 | |
| 8 | 2017 | 1 | |
| 9 | 2016 | 16 | |
| 10 | 2014 | 11 | |
| 11 | 2008 | 1 | |
| 12 | 2007 | 108 | |
| 13 | 2006 | 301 | |
| 14 | 2005 | 70 | |
| 15 | 2005 | 88 | |
| 16 | 2005 | 22 | |
| 17 | 2005 | 126 | |
| 18 | 2004 | 200 | |
| 19 | 2004 | 87 | |
| 20 | 2001 | 12 |
About Ying Mu
Ying Mu is a scholar working on Virology, Pharmacology and Biological Psychiatry, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers), HIV Research and Treatment (4 papers), Cholesterol and Lipid Metabolism (3 papers), HIV/AIDS drug development and treatment (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Estrogen and related hormone effects (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Pharmacology (406 citations), Endocrinology, Diabetes and Metabolism (265 citations) and Oncology (425 citations). Ying Mu has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Wen Xie, Hirdesh Uppal, Songrong Ren, David Toma, S. P. S. Saini, Haibiao Gong, Ronald M. Evans, Yonggong Zhai, Jie Zhou and Li Xu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.